Searches / Singapore Med J [JOURNAL]

Singapore Med J [JOURNAL]

Sun 200 papers
RSS

Response to comments on: Diagnostic classification of dermatomyositis with and without electrodiagnostic study: real-world clinical practice.

Pillai P, Mashor M, Tang MM … +1 more , Hiew FL

Singapore Med J · 2026 Jun · PMID 42359716 · Publisher ↗

Abstract loading — click title to view on PubMed.

Comments on: Diagnostic classification of dermatomyositis with and without electrodiagnostic study: real-world clinical practice.

Ijaz A, Lau KM, Hui AC

Singapore Med J · 2026 Jun · PMID 42359715 · Publisher ↗

Abstract loading — click title to view on PubMed.

Computed tomographic evaluation of bronchiolitis: unravelling the multifaceted spectrum of airways and pulmonary abnormalities.

Lee ECH, Velaga J, Haja Mohideen SM

Singapore Med J · 2026 Jun · PMID 42359714 · Publisher ↗

Abstract loading — click title to view on PubMed.

Approach to facial pain.

Ong DSM, Ramireddi GK, Lim ZV … +2 more , Lim MW, Leong AZ

Singapore Med J · 2026 Jun · PMID 42359713 · Publisher ↗

Abstract loading — click title to view on PubMed.

Glioblastoma: current challenges and future horizons.

Chan YB, Pang RKJ, Pang BC … +2 more , Yeo TT, Tan BY

Singapore Med J · 2026 Jun · PMID 42359712 · Publisher ↗

Abstract loading — click title to view on PubMed.

The role of public health specialists in tertiary hospitals in Singapore.

Tan HY, Wahab MT, Yap JC … +5 more , Foo CK, Poopalalingam R, Tan HK, Gan WH, Lee CE

Singapore Med J · 2026 Jun · PMID 42294592 · Publisher ↗

Abstract loading — click title to view on PubMed.

The journey after restart: understanding the multidimensional experience of cardiac arrest survivors.

Sim ZJ, Ng JJ, Chia YW … +3 more , Lim SL, Ong MEH, Ho AFW

Singapore Med J · 2026 Jun · PMID 42294588 · Publisher ↗

Abstract loading — click title to view on PubMed.

Clinics in diagnostic imaging (225).

Lim DXY, Lim JX, Lim BL … +1 more , Koh Y

Singapore Med J · 2026 May · PMID 42184302 · Full text

Abstract loading — click title to view on PubMed.

Approach to urticaria in primary care.

Ng IKS, Long VS, Goh LH … +1 more , Choi EC

Singapore Med J · 2026 May · PMID 42184301 · Full text

Abstract loading — click title to view on PubMed.

World Pre-eclampsia Day: are we moving in the right direction?

Gosavi A, Li S, Biswas A … +1 more , Choolani M

Singapore Med J · 2026 May · PMID 42184300 · Full text

Abstract loading — click title to view on PubMed.

World Ovarian Cancer Day: unravelling the molecular anatomy of a silent killer.

Kanneganti A, Low JJH, Huang RY … +1 more , Choolani M

Singapore Med J · 2026 May · PMID 42184299 · Full text

Abstract loading — click title to view on PubMed.

Is it time to move away from legacy inflammatory bowel disease drugs?

Leung WK

Singapore Med J · 2026 May · PMID 42184298 · Full text

Abstract loading — click title to view on PubMed.

Irritable bowel syndrome management: current insights.

Ang D

Singapore Med J · 2026 May · PMID 42184297 · Full text

Abstract loading — click title to view on PubMed.

Positioning of advanced therapies in patients with moderate-to-severe Crohn's disease.

Qiu TY, Tan CK, Ong JPL … +1 more , Ling KL

Singapore Med J · 2026 May · PMID 42184296 · Full text

The treatment landscape for Crohn's disease (CD) has evolved substantially in the 21st century with the advent of advanced therapies. Since the introduction of tumour necrosis factor (TNF) antagonists, new classes of adv... The treatment landscape for Crohn's disease (CD) has evolved substantially in the 21st century with the advent of advanced therapies. Since the introduction of tumour necrosis factor (TNF) antagonists, new classes of advanced CD therapies have been approved for use in the Asia-Pacific region, including anti-integrins, interleukin (IL)-12/23p40 inhibitors, IL-23p19 inhibitors and Janus kinase inhibitors (JAKi). In the last 10 years, biosimilars to infliximab, adalimumab and ustekinumab and generic JAKi have also become available. In this review, we discuss the indications for advanced therapies and whether certain classes of drugs are preferred for specific patient subsets. We also discuss the choice of first- and second-line agents for CD.

The human microbiome at translational crossroads: an ecological and causal perspective.

Wong SH

Singapore Med J · 2026 May · PMID 42184295 · Full text

The human microbiome has emerged as a central focus of biomedical research, driven by interest in its translational potential for chronic diseases. Although compelling associations link microbial alterations to gastroint... The human microbiome has emerged as a central focus of biomedical research, driven by interest in its translational potential for chronic diseases. Although compelling associations link microbial alterations to gastrointestinal, metabolic, neuropsychiatric and systemic conditions, successful clinical translation remains limited. This perspective contends that the principal barrier is not biological relevance but the application of reductionist thinking to an inherently complex ecological system, compounded by an incomplete understanding of causality. This review examines the gradient of causal confidence across gut-organ axes, from established roles in digestive disorders to less established distal associations, as well as highlights the epistemological challenges underlying microbiome research. A critical appraisal of current strategies, including probiotics, live biotherapeutics and faecal microbiota transplantation, suggests that progress requires ecological reasoning, causal rigour and systems-level integration. Moving from association to intervention demands approaches that account for host-microbiome complexity rather than oversimplified microbial targeting.

Collaborating to strengthen evidence-based care.

Ang TL, Oh CC

Singapore Med J · 2026 May · PMID 42184294 · Full text

Abstract loading — click title to view on PubMed.

Interest in peer support among Singaporean adults with symptoms of anxiety and depression.

Teo I, Puri J, Chodavadia P … +4 more , Ho JH, Poremski D, Fung DSS, Finkelstein E

Singapore Med J · 2026 May · PMID 42165811 · Publisher ↗

INTRODUCTION: Access to formal mental health care remains limited in Asia. Peer support can be a viable alternative gateway or complement to formal mental health care. The current study examined interest in various types... INTRODUCTION: Access to formal mental health care remains limited in Asia. Peer support can be a viable alternative gateway or complement to formal mental health care. The current study examined interest in various types of peer support, including individual versus group and virtual versus in-person, among Singaporean adults with symptoms of anxiety or depression. METHODS: A cross-sectional online survey was administered to members of a web panel. Participants with symptoms of depression or anxiety based on the Patient Health Questionnaire-4 screening tool were surveyed. Logistic regression analysis was conducted to examine factors associated with greater interest in peer support. RESULTS: A total of 350 panel members met our inclusion criteria. Of them, 77% had not received formal mental healthcare services, while 62% indicated interest in receiving peer support. The strongest preference was for one-on-one support delivered virtually. Younger age (odds ratio [OR] 1.05, P < 0.01), working in white-collar managerial as opposed to white-collar non-managerial positions (OR 1.96, P < 0.05), utilising formal health care in the last 3 months (OR 2.45, P < 0.05) and previously providing peer support (OR 7.33, P < 0.01) were associated with greater interest in receiving peer support. Most of those not interested in peer support cited concerns around confidentiality. CONCLUSION: Despite low uptake of formal mental health care, the majority of adult Singaporeans surveyed with anxiety or depression symptoms indicated interest in receiving peer support. Greater efforts to promote peer support programmes can be part of a comprehensive strategy to address rising rates of poor mental health in Singapore.

Paediatric Epstein-Barr virus-associated intracranial smooth muscle tumours.

Loh D, Chua FHZ, Wu B … +2 more , Kimpo M, Nga VDW

Singapore Med J · 2026 May · PMID 42106962 · Publisher ↗

Abstract loading — click title to view on PubMed.

Peri-procedural antibiotics for infection prevention in transjugular intrahepatic portosystemic shunt and plug-assisted retrograde transvenous obliteration: a randomised trial.

Bhashyakarla A, Pasam S, Sreekanth V … +8 more , Sharma M, Singh JR, Venishetty S, Alla M, Reddy J, Reddy DN, Tandon M, Kulkarni AV

Singapore Med J · 2026 May · PMID 42106961 · Publisher ↗

INTRODUCTION: Transjugular intrahepatic portosystemic shunt (TIPS) and plug-assisted retrograde transvenous obliteration (PARTO) are the standard of care for managing portal hypertension-related complications. However, t... INTRODUCTION: Transjugular intrahepatic portosystemic shunt (TIPS) and plug-assisted retrograde transvenous obliteration (PARTO) are the standard of care for managing portal hypertension-related complications. However, the role of peri-procedural antibiotics in preventing infections during these interventions remains unclear because of limited evidence, and this study aimed to address this gap. METHODS: In this single-centre, double-blind, placebo-controlled, randomised trial, adult patients with portal hypertension were randomised to receive ceftriaxone (1 g twice daily until discharge) or placebo. The primary outcome was the incidence of clinically significant infection defined as fever and a quick Sequential Organ Failure Assessment (qSOFA) score ≥ 2, and secondary outcomes were hospital stay duration, in-hospital mortality and adverse events. RESULTS: Of the 70 patients, 35 received placebo and 35 received ceftriaxone (antibiotic). Twenty-one patients in the placebo arm and 22 in the antibiotic arm underwent PARTO, and the rest underwent TIPS or direct intrahepatic portocaval shunt. On Kaplan-Meier analysis, the risk of clinically significant infection (fever and qSOFA ≥ 2) was 17.1% in the placebo arm and 8.6% in the antibiotic arm ( P = 0.31). Fever rates were similar (20% in the placebo arm compared with 22.9% in the antibiotic arm, P = 0.77). Hospital stay duration (4.4 ± 1.7 days in the placebo arm compared with 4.1 ± 2.2 days in the antibiotic arm, P = 0.47) and in-hospital mortality (one death per arm) were comparable. One patient in the placebo arm experienced an injection-site rash. No significant predictors of infection were identified due to the small sample size. CONCLUSION: Peri-procedural ceftriaxone did not significantly reduce infection rates in patients undergoing elective TIPS or PARTO.

Effect of flushing technique on residual anaesthetic drug content in syringes.

Lau WK, Goh KK, Bong CL … +3 more , Sin LJ, Lim TP, Lim EH

Singapore Med J · 2026 May · PMID 42106960 · Publisher ↗

INTRODUCTION: The practice of reusing the same syringe to administer different medications during anaesthesia for the same patient is common. One concern with this practice is the potential for drug incompatibility. Alth... INTRODUCTION: The practice of reusing the same syringe to administer different medications during anaesthesia for the same patient is common. One concern with this practice is the potential for drug incompatibility. Although flushing the syringe between drugs may address this concern, its effect on drug removal is unknown. The primary aim of this study was to examine the effect of flushing technique on the residual drug content in syringes of different sizes that were initially used for administering propofol and subsequently reused for administering cefazolin and morphine. METHODS: Syringes (3, 5, 10 and 20 mL) were filled with propofol (1%) and emptied. They were then flushed once, twice or three times using varying volumes of water for injection or normal saline (0.9% sodium chloride), before being reused for cefazolin. The procedure was repeated before the syringes were reused for morphine. Finally, morphine was flushed out. The expelled fluid after each flush was collected and analysed using liquid chromatography-tandem mass spectrometry. RESULTS: For the 10- and 20-mL syringes, no residual drug was detected after a single flush, regardless of the flushing fluid, using 50% or 100% syringe volume flushes. For the 3- and 5-mL syringes, no residual drug was detected after flushing once with normal saline or twice with water for injection using 50% or 100% syringe volume flushes. CONCLUSION: A minimum of two 50% syringe volume flushes with normal saline or water for injection ensured complete removal of propofol, cefazolin and morphine, regardless of syringe size. This may enable safer single-patient syringe reuse during anaesthesia, reducing syringe use, lowering costs and promoting environmental sustainability.
← Prev Page 1 of 10 Next →

About

Frequency
Sun
Papers found
200
RSS feed
Subscribe